drugset / Trial / NCT07221084
A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the PK profile, safety, and tolerability of atumelnant after single and multiple once daily (QD) oral doses in healthy Japanese and Caucasian adult participants.
Timeline
- Start
- 2025-10-28
- Primary completion
- 2026-02-07
- Completion
- 2026-02-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atumelnant | Small molecule | — | Oral |
Indications
No indication recorded.